- NAOV Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
NanoVibronix (NAOV) S-1IPO registration
Filed: 14 Feb 25, 4:16pm
Exhibit 23.3
Consent of Independent Auditor
We consent to the reference to our firm under the caption “Experts” and to the use of our reports dated February 14, 2025, with respect to the consolidated financial statements of ENvue Medical Holdings Corp. (formerly Envizion Medical Holding Corp.) included in the Registration Statement (Form S-1) and related Prospectus of NanoVibronix, Inc. for the registration of its Series G Convertible Preferred Stock and Warrants and shares of Common Stock underlying such securities.
/s/ KOST FORER GABBAY & KASIERER | |
A Member of Ernst & Young Global | |
Tel Aviv, Israel | |
February 14, 2025 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.